Cruz gave short answers to any Biogenesis-related questions during a news conference Tuesday, a day after the 33-year-old outfielder and the team finalized an $8 million, one-year contract.
"Whatever happened in the past, I look to move forward and have a great year with the Baltimore Orioles," Cruz said.
Buck Showalter and Dan Duquette introduce Nelson Cruz to the media. pic.twitter.com/hlsY7IjJsY
- Baltimore Orioles (@Orioles) February 25, 2014
Cruz was suspended for 50 games in August for a violation of Major League Baseball's drug agreement related to the sport's investigation of the Biogenesis of America anti-aging clinic.
Markakis said last summer that baseball needs stiffer penalties for violations of drug rules. On Saturday, Markakis said he still favored tougher penalties but was happy to have Cruz on the Orioles.
"My opinion doesn't change toward anything," Markakis said. "He's part of this team now and he's going to be in this clubhouse and we're going to welcome him just like anybody else. He's going to be part of this team."
Cruz hit .266 with 27 homers and 76 RBIs in 109 games last season. The suspension cost him $2,732,240 of his $10 million salary.
He signed with Baltimore more than three months after he turned a down a $14.1 million qualifying offer from the Rangers.
"It was a frustrating process, but I'm happy for the decision that I made," Cruz said. "I'm really excited for the opportunity. I like challenges and I think it's going to be a great challenge for me. Hopefully, I do my best and I look for the World Series."
Cruz is part of a late spending burst that has seen the Orioles commit $63,575,000 in salary to three players. Veteran right-hander Ubaldo Jimenez agreed to a $50 million, four-year contract and South Korean right-hander Suk-min Yoon received a three-year deal for $5,575,000.
Baltimore lost its first-round draft pick (No. 17 overall) for signing Jimenez, and its second-round selection (No. 55) for signing Cruz.
Dan Duquette, the Orioles' executive vice president of baseball operations, adopted a strategy of waiting for free-agent prices to drop.
"We've been steadily putting our team together," he said. "We signed a couple of pitchers, which we said we were going to do, and we said we were looking for a bat in the middle of our lineup, and Nelson can fill that role. We're always looking, but I don't anticipate any players of this caliber soon, but we're always looking around."